1

Diabetes Management Market - (By Technology- Glucose Test Strips, Digital Health / Digital Therapeutics, Insulin Pumps, Continuous Glucose Monitoring (CGM), Insulin Pens, Side Effect Management And Diagnosis) - Global Industry Size, Share, Trends, and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Published at : November-2018 | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

Diabetes is a metabolic disease in which the blood sugar levels of the body is increased for extended period. During last few years, there is significant increase in the prevalence of the diabetes which has led to increase in the demand for the various types of technology for diabetes. This technology includes glucose test strips, digital health / digital therapeutics, insulin pumps, continuous glucose monitoring (CGM), insulin pens, side effect management and diagnosis. Digitalization and development in the technology has led to the introduction of the advanced devices. A number of companies are involved in the development of the advanced devices which are used in the management of the diabetes.

Report coverage

Market Diabetes Management Market
Analysis Period 2015 - 2026
Base Year 2017
Forecast Data 2015 - 2026
Segments Covered By Technology and By Geography
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled Abbott, Animas, DexCom, Medtronic, Roche, Accu-Chek, Eli Lilly, Bayer, LifeScan, Novo Nordisk, Sanofi-aventis, Merck, Takeda Pharmaceuticals, Novartis, and Bristol-Myers Squibb.
Report Coverage
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Customization Scope 10 hrs of free customization and expert consultation

 

 Market Dynamics

During last decade there is a significant increase in the prevalence of the diabetes. As per the WHO, approximately 422 million people across the globe were suffering from diabetes in 2014 which is expected to increase in near future. Increasing prevalence of the diabetes is the major driving factor for the growth of the market. Obese and smokers are more prone to diabetes. Increasing patient suffering from obesity and changing lifestyle of the people has catalyzed the growth of the technology for diabetes management market. Moreover, increased the demand for the better treatment option, increasing per capita income, increasing government support, increasing healthcare expenditure, and development in the technology have boosted the growth of the market during the forecast period 2018—2026. However, lack of awakes among the people and limited availability of the skilled professionals are responsible for affecting the growth of the market negatively. In near future the market is expecting a healthy opportunity owing to the continuous increasing demand for the better technology.

Market Classification

The global technology for diabetes management market is majorly segmented into technology and region.

On the basis of technology, the market is segmented into glucose test strips, digital health / digital therapeutics, insulin pumps, continuous glucose monitoring (CGM), insulin pens, side effect management and diagnosis, and others.

Regional Overview

Regionally, the technology for diabetes management market is segmented into North America, Europe, Asia Pacific and Latin America, Middle East & Africa.

North America is expected to dominate the technology for diabetes management market owing to the presence of huge patient pool, advancement in technology, and high spending on healthcare. According to WHO, 9.2% of the American population were suffering from diabetes in 2015. Additionally, presence of a huge number of players and increasing government support will fuel the growth of the market. Europe accounts for the second leading market in the forecast period followed by the Asia Pacific. Presences of huge investment in European region, huge government support, and well developed economies have driven the growth of the European market.

Asia Pacific technology for diabetes management market expected to be the fastest growth during the forecast period of 2016—2026. The growth is majorly attributed due to presence of huge diabetic and obese patients of the region. According to the International Diabetes Federation (IDF), in 2016, approximately 60% of total global diabetic population was present in Asia of which over 114 million are in China alone. Moreover, increasing government support and increasing per capita income have fueled the growth of the Asia Pacific market. LAMEA region is expecting a steady growth during the forecast period 2018—2026.

Market Participants

Some of the major key players in the market are Abbott, Animas, DexCom, Medtronic, Roche, Accu-Chek, Eli Lilly, Bayer, LifeScan, Novo Nordisk, Sanofi-aventis, Merck, Takeda Pharmaceuticals, Novartis, and Bristol-Myers Squibb.

Market Segmentation

Market By Technology

  • Glucose Test Strips
  • Digital Health / Digital Therapeutics
  • Insulin Pumps
  • Continuous Glucose Monitoring (CGM)
  • Insulin Pens
  • Side Effect Management & Diagnosis
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Cart Summary